Cite
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
MLA
Raymond, E., et al. “A Human Breast Cancer Model for the Study of Telomerase Inhibitors Based on a New Biotinylated-Primer Extension Assay.” British Journal of Cancer, vol. 80, no. 9, July 1999, pp. 1332–41. EBSCOhost, https://doi.org/10.1038/sj.bjc.6690526.
APA
Raymond, E., Sun, D., Izbicka, E., Mangold, G., Silvas, E., Windle, B., Sharma, S., Soda, H., Laurence, R., Davidson, K., Hoff, D. D. V., & Von Hoff, D. D. (1999). A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. British Journal of Cancer, 80(9), 1332–1341. https://doi.org/10.1038/sj.bjc.6690526
Chicago
Raymond, E, D Sun, E Izbicka, G Mangold, E Silvas, B Windle, S Sharma, et al. 1999. “A Human Breast Cancer Model for the Study of Telomerase Inhibitors Based on a New Biotinylated-Primer Extension Assay.” British Journal of Cancer 80 (9): 1332–41. doi:10.1038/sj.bjc.6690526.